Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27577004 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CTSDTSHRMEN1FAAH | |
| SCHEMBL28172522 | 0.85 | TSHR (0.36) | ALDH1A1TSHR | |
| SCHEMBL23867785 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CTSDTSHRMGAMGAA | |
| SCHEMBL27407392 | 0.81 | SOAT1 (0.46) | MEN1FAAHTP53CYP1A2CYP3A4 | |
| SCHEMBL27540665 | 0.81 | KDM4E (0.33) | — | |
| SCHEMBL27645896 | 0.81 | TSHR (0.36) | ALDH1A1TSHRMEN1FAAHTP53 | |
| SCHEMBL4897752 | 0.80 | KMT2A (0.39) | ALDH1A1CTSDTSHRMEN1SOAT1 | |
| SCHEMBL321683 | 0.80 | SOAT1 (0.49) | TSHRMEN1FAAHTP53CYP1A2 | |
| SCHEMBL28053482 | 0.79 | KDM4E (0.40) | ALDH1A1TP53CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL27661788 | 0.79 | TRPA1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101910194-B | Double affinity polypeptides for purification | 科雷托公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-105738612-A | Cell detection methods and reagents having a releasable labelling moiety | 美天施生物科技有限责任公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105683217-A | Antigen binding proteins that bind to PD-1 | 索伦托治疗有限公司 | 2016-06-15 | — | — | CN | disclosed |
| CN-105524164-A | Factor VIII molecules with reduced VWF binding | NOVO NORDISK AS | 2016-04-27 | — | — | CN | disclosed |
| CN-102770449-B | Factor VIII molecules with reduced VWF binding | NOVO NORDISK A/S (DK) | 2016-02-24 | — | — | CN | disclosed |
| CN-105264376-A | Oligosaccharide conjugates and methods of use | SEC DEP FOR ENVIRONMENT FOOD AND RURAL AFFAIRS | 2016-01-20 | — | — | CN | disclosed |
| CN-105050618-A | Antigen binding proteins that bind to c-Met | SORRENTO THERAPEUTICS INC | 2015-11-11 | — | — | CN | disclosed |
| CN-105051065-A | Antigen binding proteins that bind CCR2 | SORRENTO THERAPEUTICS INC | 2015-11-11 | — | — | CN | disclosed |
| CN-104994872-A | Antigen binding proteins that bind igf1r | SORRENTO THERAPEUTICS INC | 2015-10-21 | — | — | CN | disclosed |
| CN-104736168-A | Antigen binding proteins that bind to PD-L1 | SORRENTO THERAPEUTICS INC | 2015-06-24 | — | — | CN | disclosed |
| CN-100387616-C | Method for obtaining antigenic structures enhancing specific cross reactivity | CENTO DE INGENIERIA GENETICA Y (CU) | 2008-05-14 | — | — | CN | disclosed |
| CN-100339393-C | PEG-conjugates of HGF-NK 4 | HOFFMANN LA ROCHE (CH) | 2007-09-26 | — | — | CN | disclosed |
| CN-1997666-A | Polyethylene glycol modified interferon compositions and methods of use thereof | INTERMUNE INC (US) | 2007-07-11 | — | — | CN | disclosed |
| CN-1938040-A | Oxytocin controlled release formulations and methods of using same | PR PHARMACEUTICALS (US) | 2007-03-28 | — | — | CN | disclosed |
| CN-1777440-A | Method for preparing site-specific protein conjugate | PR PHARMACEUTICALS INC (US) | 2006-05-24 | — | — | CN | disclosed |
| EP-1605894-A2 | OXYTOCIN CONTROLLED RELEASE FORMULATIONS AND METHODS OF USING SAME | PR Pharmaceuticals (US) | 2005-12-21 | — | — | EP | disclosed |
| CN-1571679-A | PEG-conjugates of HGF-NK4 | HOFFMANN LA ROCHE (CH) | 2005-01-26 | — | — | CN | disclosed |
| WO-2004078147-A2 | OXYTOCIN CONTROLLED RELEASE FORMULATIONS AND METHODS OF USING SAME | PR PHARMACEUTICALS (US) | 2004-09-16 | — | — | WO | disclosed |
| CN-1446094-A | Method for obtaining antigenic structures enhancing specific cross reactivity | CENTO DE INGENIERIA GENETICA Y (CU) | 2003-10-01 | — | — | CN | disclosed |
| CN-1230216-A | Breakable signal element apparatus and method | BURSTEIN LAB INC (US) | 1999-09-29 | — | — | CN | disclosed |